Patents by Inventor Robert T. Standridge

Robert T. Standridge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4125538
    Abstract: Substituted 5-phenyl-2,3,4,5-tetrahydro-1,4-benzoxazepines of the formula ##STR1## wherein R.sup.1 and R.sup.2 are each methyl or, when taken together with the nitrogen to which they are attached, represent pyrrolidino, R.sup.3 and R.sup.4 are the same or different and represent hydrogen, chloro, fluoro, bromo, iodo, nitro, (lower)alkyl, trifluoromethyl, (lower)alkoxy, trifluoromethoxy or (lower)alkylthio, and n is an integer from 1 to 4, and their nontoxic pharmaceutically acceptable acid addition salts, are valuable analgesic and/or antitussive agents.
    Type: Grant
    Filed: February 4, 1977
    Date of Patent: November 14, 1978
    Assignee: Bristol-Myers Company
    Inventor: Robert T. Standridge
  • Patent number: 4105695
    Abstract: Compounds of the formula ##STR1## wherein R.sup.1 is Cl, Br, (lower)alkylthio or ##STR2## in which R.sup.3 is H or (lower)alkyl including the racemic mixtures and the dextrorotatory and levorotatory isomers, and the pharmaceutically acceptable non-toxic salts thereof have been found to enhance the learning capacity of mammals, including man, and to improve the mental alertness and attitudes of geriatrics without producing the undesirable stimulant side effects associated with the use of amphetamines.
    Type: Grant
    Filed: May 11, 1977
    Date of Patent: August 8, 1978
    Assignee: Bristol-Myers Company
    Inventors: Richard A. Partyka, Robert T. Standridge, Henry G. Howell, Alexander T. Shulgin